Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Mallinckrodt
Baxter
McKinsey
Healthtrust
Chubb
Fish and Richardson
Citi
Farmers Insurance

Generated: May 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,828,339

« Back to Dashboard

Which drugs does patent 6,828,339 protect, and when does it expire?

Patent 6,828,339 protects AMLODIPINE BESYLATE and is included in one NDA.

This patent has four patent family members in four countries.

This patent has expired prematurely due to non-payment of maintenance fees. See details below.
Summary for Patent: 6,828,339
Title: Amlodipine salt forms and processes for preparing them
Abstract:Amlodipine besylate forms are described, including amlodipine besylate hydrates and novel amlodipine besylate anhydrates. A method of making various amlodipine besylate forms from an aqueous medium as well as the use of the same as a calcium channel blocker are described.
Inventor(s): Ettema; Gerrit J. B. (Nijmegen, NL), Hoorn; Hans (Nijmegen, NL), Lemmens; Jacobus M. (Nijmegen, NL)
Assignee: Synthon BV (Nijmegen, NL)
Application Number:10/300,003
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,828,339
Patent Claim Types:
see list of patent claims
Compound; Composition; Dosage form;

Drugs Protected by US Patent 6,828,339

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Synthon Pharms AMLODIPINE BESYLATE amlodipine besylate TABLET, ORALLY DISINTEGRATING;ORAL 022026-001 Sep 27, 2007 DISCN No No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Synthon Pharms AMLODIPINE BESYLATE amlodipine besylate TABLET, ORALLY DISINTEGRATING;ORAL 022026-002 Sep 27, 2007 DISCN No No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Synthon Pharms AMLODIPINE BESYLATE amlodipine besylate TABLET, ORALLY DISINTEGRATING;ORAL 022026-003 Sep 27, 2007 DISCN No No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 6,828,339

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 037565 ➤ Sign Up
Australia 2002343257 ➤ Sign Up
European Patent Office 1448197 ➤ Sign Up
World Intellectual Property Organization (WIPO) 03043635 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Merck
Boehringer Ingelheim
Queensland Health
Farmers Insurance
Accenture
Baxter
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.